ARCHIVES

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

This article is from The Cancer Letter archive.

Vol. 28 No. 18 | May 3, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

In Brief: Kansas to Provide State Funds For Cancer Center; Meeting On Freestanding Centers In Philadelphia

May 22, 1987

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

President Clinton Seeks 8% Increase For NCI; Most Institute Take Cuts In $10 Bll. NIH Budget

April 16, 1993

Professional Societies: Three Groups To File brief In Fisher’s Appeal

October 11, 1996

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014